Rapid reduction in triglyceride levels by therapeutic plasma exchange in patients with hypertriglyceridemic pancreatitis

J Clin Apher. 2022 Feb;37(1):82-90. doi: 10.1002/jca.21954. Epub 2021 Nov 30.

Abstract

Objective: To investigate the effect of therapeutic plasma exchange (TPE) on lowering triglyceride (TG) levels in patients with hypertriglyceridemic pancreatitis (HLAP).

Methods: The TG-lowering in patients with HLAP was compared between the TPE group and conservative treatment group (non-TPE). The primary outcome was TG reduction to less than 500 mg/dL within 48 hours.

Results: The primary outcome was significantly correlated with TPE (univariate analysis odds ratio [OR] 2.74; 95% confidence interval [CI] 1.30-5.79, P = .008; multivariate analysis OR 3.03; 95% CI 1.28-7.19, P = .012). At 24 and 48 hours, conservative treatment resulted in a 48.24% and 70.44% reduction in TG, while TPE resulted in a 70.91% and 76.39% reduction in TG, respectively. A more rapid decrease of in TGs in a short period was clearly associated with TPE (P < .001 for interaction). After 72 hours, the TGs decreased by approximately 77% in both groups, with no significant difference (P = .563). There was no difference between groups in clinical outcomes over the acute time period or over the longer term.

Conclusions: In patients with HLAP, TPE resulted in a short-term and rapid reduction in plasma TG concentrations, with no significant advantage over non-TPE after 72 hours.

Keywords: acute pancreatitis; effectiveness; hypertriglyceridemia; prognosis; therapeutic plasma exchange; triglycerides.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Female
  • Humans
  • Hypertriglyceridemia / blood*
  • Hypertriglyceridemia / complications*
  • Hypertriglyceridemia / therapy*
  • Male
  • Middle Aged
  • Pancreatitis / complications*
  • Plasma Exchange*
  • Time Factors
  • Treatment Outcome
  • Triglycerides / blood*

Substances

  • Triglycerides